Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,018 public trials 711 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

NCT02597049

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Medical Group of Encino Encino, California, United States
  • National Research Institute Huntington Park, California, United States
  • National Research Institute Los Angeles, California, United States
  • New Horizon Research Center Miami, Florida, United States
View all 41 locations
View Trial Details
Completed

Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs

NCT02752412

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 392002 Adachi-Ku, Japan
  • Investigational Site Number 392132 Annaka-Shi, Japan
  • Investigational Site Number 392009 Arakawa-Ku, Japan
  • Investigational Site Number 392152 Asahikawa-Shi, Japan
View all 122 locations
View Trial Details
Completed

Indian Phenotype Registry

NCT03363594

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Research Site Guntur, Andhra Pradesh, India
  • Research Site Kākināda, Andhra Pradesh, India
  • Research Site Madanapalle, Andhra Pradesh, India
  • Research Site Nellore, Andhra Pradesh, India
View all 197 locations
View Trial Details
Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

NCT02749890

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 392002 Adachi-Ku, Japan
  • Investigational Site Number 392009 Arakawa-Ku, Japan
  • Investigational Site Number 392025 Atsugi-Shi, Japan
  • Investigational Site Number 392060 Bunkyō City, Japan
View all 61 locations
View Trial Details
Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

NCT02752828

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 392002 Adachi-Ku, Japan
  • Investigational Site Number 392132 Annaka-Shi, Japan
  • Investigational Site Number 392009 Arakawa-Ku, Japan
  • Investigational Site Number 392025 Atsugi-Shi, Japan
View all 113 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

NCT03495102

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Synexus- Chandler Chandler, Arizona, United States
  • Synexus/Central Arizona Medical Associates, PC Mesa, Arizona, United States
  • Central Phoenix Med Clinic LLC Phoenix, Arizona, United States
  • Arkansas Clinical Research Little Rock, Arkansas, United States
View all 208 locations
View Trial Details

Related conditions